IXC 5.26% 7.2¢ invex therapeutics ltd

Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial, page-21

  1. 390 Posts.
    lightbulb Created with Sketch. 47
    Nice to see it gaining momentum. Not the most reputable publication, but large audience
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
-0.004(5.26%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.3¢ 7.3¢ 7.2¢ $2.243K 30.74K

Buyers (Bids)

No. Vol. Price($)
1 38792 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 4000 1
View Market Depth
Last trade - 12.37pm 22/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.